cis-N,N-Dimethyl-2-methyl-cyclohexylamin | 1071691-02-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: cis-N,N-Dimethyl-2-methyl-cyclohexylamin
• 英文别名: cis-2-Methyl-N,N-dimethylcyclohexylamin；(1R,2S)-N,N,2-trimethylcyclohexan-1-amine
• CAS: 1071691-02-5
• 化学式: C₉H₁₉N
• 分子量: 141.257
• InChiKey: CMWMUSYWBQEHEJ-DTWKUNHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] PHTHALAZINE DERIVATIVES OF FORMULA (I) AS PCAF AND GCN5 INHIBITORS FOR USE IN THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS PHTALAZINE DE FORMULE (I) UTILISÉS COMME INHIBITEURS DE LA PCAF ET DE LA GCN5 DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER
  申请人：GENENTECH INC

  公开号：WO2016036954A1

  公开（公告）日：2016-03-10

  The present invention relates to methods for treating PCAF and GCN5 mediated disorders using a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein ring A, R1, R3, R4, R5, and each Re have any of the values defined in the specification. Also included are novel compounds of Formula (I) and salts thereof, as well as pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.

  本发明涉及使用式(I)的化合物或其药学上可接受的盐治疗由PCAF和GCN5介导的疾病的方法：其中环A、R1、R3、R4、R5和每个Re具有规范中定义的任何值。还包括式(I)的新化合物及其盐，以及包含式(I)的化合物或其药学上可接受的盐的药物组合物。
• THERAPEUTIC COMPOUNDS AND USES THEREOF
  申请人：GENENTECH, INC.

  公开号：US20170275289A1

  公开（公告）日：2017-09-28

  The present invention relates to methods for treating PCAF and GCN5 mediated disorders using a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein ring A, R 1 , R 3 , R 4 , R 5 , and each R e have any of the values defined in the specification. Also included are novel compounds of Formula (I) and salts thereof, as well as pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.